Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Steve Lundy becomes AspenBio CEO

This article was originally published in Clinica

Executive Summary

Diagnostics firm AspenBio Pharma has appointed Steve Lundy to the position of CEO. Mr Lundy, who will also join the company’s board of directors, recently served as CEO of bacterial diagnostics specialist MicroPhage. He has also held senior executive roles at Vermillion and GeneOhm (which was acquired by BD in 2006). Mr Lundy will replace Daryl Faulkner, who held the role of interim CEO since 2009. Mr Faulkner will continue as executive chairman. AspenBio (Castle Rock, Colorado) is currently developing the AppyScore, a blood-based test for evaluating patients suspected of having acute appendicitis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077101

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel